Successful transplantation of human hepatic stem cells with restricted localization to liver using hyaluronan grafts

Hepatology

Volumn 57, Issue 2, 2013, Pages 775-784

  Turner, Rachael A ^a   Wauthier, Eliane ^a   Lozoya, Oswaldo ^a   McClelland, Randall ^a   Bowsher, James E ^c   Barbier, Claire ^a   Prestwich, Glenn ^b   Hsu, Edward ^c   Gerber, David A ^a   Reid, Lola M ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON TETRACHLORIDE; COLLAGEN TYPE 3; HYALURONIC ACID; LAMININ;

ANIMAL EXPERIMENT; ARTICLE; CELL CULTURE; CELL EXPANSION; CELL SURVIVAL; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; LIVER GRAFT; LIVER INJURY; MALE; MICROENVIRONMENT; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; TRANSPLANTATION OF HUMAN HEPATIC STEM CELL;

ANIMALS; CARBON TETRACHLORIDE POISONING; CELLS, CULTURED; HUMANS; HYALURONIC ACID; LIVER; MICE; STEM CELL TRANSPLANTATION;

EID: 84873300649     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.26065     Document Type: Article

References (43)

1. Strom S, Fisher RA, Thompson MT, Sanyal AJ, Cole PE, Ham JM, et al. Hepatocyte transplantation as a bridge to orthotopic liver transplantation in terminal liver failure. Transplantation 1997; 63: 559-569.
2. Fox IJ, Chowdhury JR. Hepatocyte transplantation. Am J Transplant 2004;(4 Suppl. 6): 7-13.
3. Najimi M, Sokal E. Liver cell transplantation. Minerva Pediatr 2005; 57: 243-257.
4. Stephenne X, Najimi M, Sibille C, Nassogne MC, Smets F, Sokal EM. Sustained engraftment and tissue enzyme activity after liver cell transplantation for argininosuccinate lyase deficiency. Gastroenterology 2006; 130: 1317-1323.
5. Gupta S, Bhargava KK, Novikoff PM. Mechanisms of cell engraftment during liver repopulation with hepatocyte transplantation. Semin Liver Dis 1999; 19: 15-26.
6. Weber A, Groyer-Picard MT, Franco D, Dagher I. Hepatocyte transplantation in animal models. Liver Transpl 2009; 15: 7-14.
7. Dagher I, Boudechiche L, Branger J, Coulomb-Lhermine A, Parouchev A, Sentilhes L, et al. Efficient hepatocyte engraftment in a nonhuman primate model after partial portal vein embolization. Transplantation 2006; 82: 1067-1073.
8. Ambrosino G, Varotto S, Basso SM, Cecchetto A, Carraro P, Naso A, et al. Hepatocyte transplantation in the treatment of acute liver failure: microencapsulated hepatocytes versus hepatocytes attached to an autologous biomatrix. Cell Transplant 2003; 12: 43-49.
9. Susick R, Moss N, Kubota H, LeCluyse E, Hamilton G, Luntz T, et al. Hepatic progenitors and strategies for liver cell therapies. Ann N Y Acad Sci 2002; 943: 398-419.
10. Turner R, Mendel G, Wauthier E, Barbier C, Reid L. Hyaluronan-supplemented buffers preserve adhesion mechanisms facilitating cryopreservation of human hepatic stem/progenitor cells. Cell Transplantation 2012; doi:http://dx.doi.org/10.3727/096368912X637000.
11. Khan AA, Shaik MV, Parveen N, Rajendraprasad A, Aleem MA, Habeeb MA, et al. Human fetal liver-derived stem cell transplantation as supportive modality in the management of end-stage decompensated liver cirrhosis. Cell Transplantation 2010; 19: 1-10.
12. Turner R, Gerber D, Reid L. The future of cell transplant therapies: a need for tissue grafting. Transplantation 2010; 90: 807-810.
13. Zhang L, Theise N, Chua M, Reid LM. The stem cell niche of human livers: symmetry between development and regeneration. HEPATOLOGY 2008; 48: 1598-1607.
14. Wang Y, Yao H-L, Cui C-B, Wauthier E, Barbier C, Costello MJ, et al. Paracrine signals from mesenchymal cell populations govern the expansion and differentiation of human hepatic stem cells to adult liver fates. HEPATOLOGY 2010; 52: 1443-1454.
15. Hayes A, Tudor D, Nowell M, Caterson B, Hughes C. Unique forms of chondroitin sulfate proteoglycans in stem cell niches. J Histochem Cytochem 2007; 56: 125-138.
16. Luo Y, Kirker KR, Prestwich GD. Cross-linked hyaluronic acid hydrogel films: new biomaterials for drug delivery. J Control Release 2000; 69: 169-184.
17. Shepard S, Becker H, Hartmann JX. Using hyaluronic acid to create a fetal-like environment in vitro. Ann Plast Surg 1996; 36: 65-69.
18. Vrochides D, Papanikolaou V, Pertoft H, Antoniades AA, Heldin P. Biosynthesis and degradation of hyaluronan by nonparenchymal liver cells during liver regeneration. HEPATOLOGY 1996; 23: 1650-1655.
19. Ogata T, Okuda K, Ueno T, Saito N, Aoyagi S. Serum hyaluronan as a predictor of hepatic regeneration after hepatectomy in humans. Eur J Clin Invest 1999; 29: 780-785.
20. Shu XZ, Liu Y, Luo Y, Roberts MC, Prestwich GD. Disulfide cross-linked hyaluronan hydrogels. Biomacromolecules 2002; 3: 1304-1311.
21. Prestwich GD. Hyaluronic acid-based clinical biomaterials derived for cell and molecule delivery in regenerative medicine. J Control Release 2011; 155: 193-199.
22. Burdick JA, Prestwich GD. Hyaluronic acid hydrogels for biomedical applications. Adv Mater 2011; 23: H41-H56.
23. Kubota H, Reid LM. Clonogenic hepatoblasts, common precursors for hepatocytic and biliary lineages, are lacking classical major histocompatibility complex class I antigen. Proc Natl Acad Sci U S A 2000; 97: 12132-12137.
24. Lozoya OA, Wauthier E, Turner RA, Barbier C, Prestwich GD, Guilak F, et al. Regulation of hepatic stem/progenitor phenotype by microenvironment stiffness in hydrogel models of the human liver stem cell niche. Biomaterials 2011; 32: 7389-7402.
25. Schmelzer E, Zhang L, Bruce A, Wauthier E, Ludlow J, Yao HL, et al. Human hepatic stem cells from fetal and postnatal donors. J Exp Med 2007; 204: 1973-1987.
26. Schmelzer E, Wauthier E, Reid LM. The phenotypes of pluripotent human hepatic progenitors. Stem Cells 2006; 24: 1852-1858.
27. Schmelzer E, Reid LM. Telomerase activity in human hepatic stem cells, hepatoblasts and hepatocytes from neonatal, pediatric, adult and geriatric donors. Eur J Hepatol Gastroenterol 2009; 21: 1191-1198.
28. Turner WS, Schmelzer E, McClelland R, Wauthier E, Chen W, Reid LM. Human hepatoblast phenotype maintained by hyaluronan hydrogels. J Biomed Mater Res B Appl Biomater 2007; 82: 156-168.
29. Turner WS, Seagle C, Galanko JA, Favorov O, Prestwich GD, Macdonald JM, et al. Nuclear magnetic resonance metabolomic footprinting of human hepatic stem cells and hepatoblasts cultured in hyaluronan-matrix hydrogels. Stem Cells 2008; 26: 1547-1555.
30. Shu XZ, Ahmad S, Liu Y, Prestwich GD. Synthesis and evaluation of injectable, in situ crosslinkable synthetic extracellular matrices for tissue engineering. J Biomed Mater Res A 2006; 79: 902-912.
31. Shu XZ, Liu Y, Palumbo F, Luo Y, Prestwich GD. In situ crosslinkable glycosaminoglycan hydrogels for tissue engineering. Biomaterials 2004; 25: 1339-1348.
32. Vanderhooft JL, Alcoutlabi M, Magda JJ, Prestwich GD. Rheological properties of cross-linked hyaluronan-gelatin hydrogels for tissue engineering. Macromolecular Bioscience 2009; 9: 20-28.
33. Cai S, Liu Y, Zheng Shu X, Prestwich GD. Injectable glycosaminoglycan hydrogels for controlled release of human basic fibroblast growth factor. Biomaterials 2005; 26: 6054-6067.
34. Brooks AR, Harkins RN, Wang P, Qian HS, Liu P, Rubanyi GM. Transcriptional silencing is associated with extensive methylation of the CMV promoter following adenoviral gene delivery to muscle. J Gene Med 2004; 6: 395-404.
35. Puppi J, Strom SJ, Hughes RD, Bansal S, Castell JV, Dagher I, et al. Improving the techniques for human hepatocyte transplantation: report from a consensus meeting in London. Cell Transplantation 2012; 21: 1-10.
36. Hoppo T, Komori J, Manohar R, Stolz DB, Lagasse E. Rescue of lethal hepatic failure by hepatized lymph nodes in mice. Gastroenterology 2011; 140: 656-666.e2.
37. Turner R, Lozoya O, Wang Y, Cardinale V, Gaudio E, Alpini G, et al. Human hepatic stem cell and maturational liver lineage biology. HEPATOLOGY 2011; 53: 1035-1045.
38. Engler AJ, Sen S, Sweeney HL, Discher DE. Matrix elasticity directs stem cell lineage specification. Cell 2006; 126: 677-689.
39. Yeung T, Georges PC, Flanagan LA, Marg B, Ortiz M, Funaki M, et al. Effects of substrate stiffness on cell morphology, cytoskeletal structure, and adhesion. Cell Motil Cytoskeleton 2005; 60: 24-34.
40. Kofidis T, Lebl DR, Martinez EC, Hoyt G, Tanaka M, Robbins RC. Novel injectable bioartificial tissue facilitates targeted, less invasive, large-scale tissue restoration on the beating heart after myocardial injury. Circulation 2005; 112(9 Suppl.): I173-I177.
41. Christman KL, Vardanian AJ, Fang Q, Sievers RE, Fok HH, Lee RJ. Injectable fibrin scaffold improves cell transplant survival, reduces infarct expansion, and induces neovasculature formation in ischemic myocardium. J Am Coll Cardiol 2004; 44: 654-660.
42. Gutowska A, Jeong B, Jasionowski M. Injectable gels for tissue engineering. Anat Rec 2001; 263: 342-349.
43. Hong Y, Gao C, Shen J. Research development of injectable scaffolds for tissue regeneration. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 2007; 24: 463-465.